Lunate Capital Ltd
Position in RVMD — Revolution Medicines, Inc.
CIK 2056786
AL MARYAH ISLAND, ABU DHABI, C0
Position in RVMD
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$53,395,112
-$121,532,218 QoQ
Shares Held
999,050
-62.2% QoQ
Ownership
0.466%
of shares outstanding
% of Portfolio
44.66%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lunate Capital Ltd holds $3,611,043 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NMRA |
Neumora Therapeutics, Inc.
|
2,124,143 | $3,611,043 |
All Filings in RVMD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 RVMDW | — | 450,000 | Shares | Defined | 2026-04-16 | |
| 2026-03-31 | $53,395,112 | 549,050 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 RVMDW | — | 450,000 | Shares | Defined | 2026-01-23 | |
| 2025-12-31 | $174,927,330 | 2,196,200 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 RVMDW | — | 450,000 | Shares | Defined | 2025-11-20 | |
| 2025-09-30 | $102,562,540 | 2,196,200 | Shares | Defined | 2025-11-20 | |
| 2025-06-30 RVMDW | — | 450,000 | Shares | Defined | 2025-07-17 | |
| 2025-06-30 | $80,798,198 | 2,196,200 | Shares | Defined | 2025-07-17 | |
| 2025-03-31 | $77,657,632 | 2,196,200 | Shares | Defined | 2025-04-25 | |
| No filing history on record for this holder in this stock. | ||||||